Previous studies showed that Pien Tze Huang, a Chinese folk medicine well known for its therapeutic activity in treating liver diseases, protected the liver against carbon tetrachloride (CCl4)–induced damage in mice. In the present study, natural musk, one of the important ingredients of Pien Tze Huang, was replaced by a formulated substitute, and the new formulation of Pien Tze Huang was shown to have similar chromatographic patterns to the original Pien Tze Huang in gas chromatography–mass spectrometry and high performance liquid chromatography. When used in treating mice with CCl4–or galactosamine–induced liver damage, both the original and new formulations of Pien Tze Huang were found to be able to suppress to a similar extent both the histopathological changes in the liver and the elevation of serum alanine aminotransferase and aspartate amino–transferase. Necrosis, cellular ballooning, microvesicular steatosis and lymphocytes infiltration were all significantly reduced in the damaged liver. In hepatoma cells, both formulations activated the activator protein 1 (AP1) enhancer sequence, indicating that both of them were able to act through the JNK signal transduction pathway. The results of the present study showed that the substitution for natural musk does not affect the hepatoprotective activities of Pien Tze Huang. It is also postulated that both formulations protect the liver through regulating signal transduction in the cell.
Hall RL . Clinical pathology of laboratory animals. In Gad SC , Chengelis CP eds. Animal models in toxicology. New York, NY: Marcel Dekker , 1992: 794–794.
2.
Lin SC , Chung TC , Lin CC , Ueng TH , Lin YH , Lin SY , Wang LY . Hepatoprotective effects of Arctium lappa on carbon tetrachloride–and acetaminophen–induced liver damage . Am J Chin Med2000; 28: 167–173 .
3.
Lee KKH , Kwong WH , Chau FT , Yew DT , Chan WY . Pien Tze Huang protects the liver against carbon tetrachloride–induced damage . Pharmacol Toxicol2002; 91: 185–192 .
4.
Recknagel RO , Glende EA Jr . Carbon tetrachloride hepatotoxicity: An example of lethal cleavage . CRC Crit Rev Toxicol1973; 2: 263–297 .
5.
Keppler D , Lesch R , Reutter W , Decker K . Experimental hepatitis induced by D–galactosamine . Exp Mol Pathol1968; 9: 279–290 .
6.
Wong FWY , Chan WY , Lee SST . Resistance to carbon tetrachloride–induced hepatotoxicity in mice which lack CYP2E1 expression . Toxicol Appl Pharmacol1998; 153: 109–118 .
7.
Sipes IG , Stripp B , Krishna G , Maling HM , Gillette JR . Enhanced hepatic microsomal activity by pretreatment of rats with acetone or isopropanol . Proc Soc Exp Biol Med1973; 142: 237–240 .
8.
Koch RR , Glende EA Jr , Recknagel RO . Hepatotoxicity of bromotrichloromethane–bond dissociation energy and lipid peroxidation . Biochem Pharmacol1974; 23: 2907–2915 .
Recknagel RO , Glende EA Jr , Dolak JA , Waller RL . Mechanisms of carbon tetrachloride toxicity . Pharmacol Ther1989; 43: 139–154 .
11.
Packer JE , Slater TF , Willson RL . Reactions of the carbon tetrachloride–related peroxy free radical (CCl3O2) with amino acids: Pulse radiolysis evidence . Life Sci1978; 23: 2617–2620 .
12.
McCay PB , Lai EK , Poyer JL , DuBose CM , Janzen EG . Oxygen–and carbon–centered free radical formation during carbon tetrachloride metabolism: Observation of lipid radicals in vivo and in vitro . J Biol Chem1984; 259: 2135–2143 .
13.
Albano E , Tomasi A , Goria–Gatti L , Poli G , Vannini V , Dianzani MU . Free radical metabolism of alcohols by rat liver microsomes . Free Radic Res Commun1987; 3: 243–249 .
14.
Connor HD , Lacagnin LB , Knecht KT , Thurman RG , Mason RP . Reaction of glutathione with a free radical metabolite of carbon tetrachloride . Mol Pharmacol1990; 37: 443–451 .
15.
Brent JA , Rumack BH . Role of free radicals in toxic hepatic injury II . Clin Toxicol1993; 31: 173–196 .
16.
Maley F , Tarentino AL , McGarrahan JF , Del–Giacco R . The metabolism of D–galactosamine and N–acetyl–D galactosamine in rat liver . Biochem J1968; 107: 637–644 .
17.
Keppler D , Rudigier JFM , Bischoff E , Decker K . The trapping of uridine phosphates by D–galactosamine, D–glucosamine and 2–deoxy–D–galatose . Eur J Biochem1970; 17: 246–253 .
18.
Keppler D , Decker K . Studies on the mechanism of galactosamine–1–phosphate and its inhibition of UDP–glucose pyrophosporylase . Eur J Biochem1969; 10: 219–225 .
19.
Decker K , Keppler D , Pausch J . The regulation pyrimidine nucleotide level and its role in experimental hepatitis . Adv Enzyme Regul1973; 11: 205–230 .
20.
Decker K , Keppler D . Galactosamine hepatitis: Key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death . Rev Physiol Biochem Pharmacol1974; 71: 78–106 .
21.
El–Mofty SK , Scrutton MC , Serroni A , Nicolino C , Farber JL . Early, reversible plasma membrane injury in galactosamine–induced liver cell death . Am J Pathol1975; 79: 579–596 .
22.
Yoshikawa T , Yokoe N , Takemura S , Kato H , Hotta T , Matsumura N , Ikezaki M , Hosokawa K , Kondo M . Lipid peroxidation and lysosomal enzymes in D–galactosamine hepatitis and its protection by vitamin E . Gastroenterol Jpn1979; 14: 31–39 .
23.
MacDonald JR , Beckstead JH , Smuckler EA . An ultraflstructural and histochemical study of the prominent in‘ammatory response in D(1-)–galactosamine hepatotoxicity . Br J Exp Pathol1987; 68: 189–199 .
24.
Dabeva MD , Shafritz DA . Activation, proliferation, and differentiation of progenitor cells into hepatocytes in the D–galactosamine model of liver regeneration . Am J Pathol1993; 143: 1606–1620 .
25.
Lim HK , Kim HS , Choi HS , OH S , Jang CG , Choi J , Kim SH , Chang MJ . Effects of acetylbergenin against D–galactosamine–induced hepatotoxicity in rats . Pharmacol Res2000; 42: 471–474 .
26.
Lim HK , Kim HS , Choi HS , Choi JW , Kim SH , Chang MJ . Effects of bergenin, the major constituent of mallotus japonicus against D–galactosamine–induced hepatotoxicity in rats . Pharmacol2001; 63: 71–75 .
27.
Quintero A , Pedraza CA , Siendones E , Kamal ElSaid AM , Colell A , Garcia–Ruiz C , Montero JL , De La Mata M , Fernandez–Checa JC , Mino G , Muntane J . PGE1 protection against apoptosis induced by D–galactosa–mine is not related to the modulation of intracellular free radical production in primary culture of rat hepatocytes . Free Radic Res2002; 36: 345–355 .
28.
Letteron P , Labbe G , Degott C , Berson A , Fromenty B , Delaforge M , Larrey D , Pessayre D . Mechanism for the protective effects of sulymarin against carbon tetrachloride–induced lipid peroxidation and hepatotoxi–city in mice. Evidence that silymarin acts both as an inhibitor of metabolic activation and as a chain–breaking antioxidant . Biochem Pharmacol1990; 39: 2027–2034 .
29.
Kim HS , Lim HK , Chung MW , Kim YC . Antihepatotoxicity activity of bergenin, the major constituent of Mallotus japonicus, on carbon tetrachloride–intoxicated hepatocytes . J Ethnopharmacol2000; 69: 79–83 .
30.
Jeong H , You H , Park S , Moon A , Chung Y , Kang S , Chun H . Hepatoprotective effects of 18beta–glycyrrhe–tinic acid on carbon tetrachloride–induced liver injury: inhibition of cytochrome P450 2E1 expression . Pharmacol Res2002; 46: 221–227 .
31.
Lee KJ , Jeong HG . Protective effect of Platycodi radix on carbon tetrachloride–induced hepatotoxicity . Food Chem Toxicol2002; 40: 517–525 .
32.
Bishayi B , Roychowdhury S , Ghosh S , Sengupta M . Hepatoprotective and immunomodulatory properties of Tinospora cordifolia in CCl4 intoxicated mature albino rats . J Toxicol Sci2002; 27: 139–146 .
33.
Muriel P , Alba N , Pérez–Á lvarez VM , Shibayama M , Tsutsumi VK . Kupffer cells inhibition prevents hepatic lipid peroxidation and damage induced by carbon tetrachloride . Comp Biochem Physiol Part C2001; 130: 219–226 .
34.
Sass G , Heinlein S , Agli A , Bang R , Schü mann J , Tiegs G . Cytokine expression in three mouse models of experimental hepatitis . Cytokine2002; 19: 115–120 .
35.
Kon K , Ikejima K , Hirose M , Yoshikawa M , Enomoto N , Kitamura T , Takei Y , Sato N . Pioglitazone prevents early–phase hepatic fibrogenesis caused by carbon tetrachloride . Biochem Biophys Res Commun2002; 291: 55–61 .
36.
Angel P , Karin M . The role of Jun, Fos and the AP–1 complex in cell–proliferation and transformation . Biochem Biophys Acta1991; 1072: 129–157 .
37.
Karin M , Liu Z , Zandi E . AP–1 function and regulation . Curr Opin Cell Biol1997; 9: 240–246 .
38.
Davis RJ . Signal transduction by the JNK group of MAP kinases . Cell2000; 103: 239–252 .
39.
Weston CR , Davis RJ . The JNK signal transduction pathway . Curr Opin Gene Dev2002; 12: 14–21 .
40.
Haber BA , Mohn KL , Diamond RH , Taub R . Induction patterns of 70 genes during nine days after hepatectomy define the temporal course of liver regeneration . J Clin Investig1993; 91: 1319–1326 .
41.
Westwick JK , Weitzel C , Leffert HL , Brenner DA . Activation of Jun kinase is an early event in hepatic regeneration . J Clin Invest1995; 95: 803–810 .
42.
Hilberg F , Aguzzi A , Howells N , Wagner EF . c–jun is essential for normal mouse development and hepato–genesis . Nature1993; 365: 179–181 .
43.
Taub R . Liver regeneration in health and disease . Clin Lab Med1996; 16: 341–360 .
44.
Heim MH , Gamboni G , Beglinger C , Gyr K . Specific activation of AP–1 but not Stat3 in regenerating liver in mice . Eur J Clin Invest1997; 27: 948–955 .
45.
Chen FK . The assays of the active ingredients of some common traditional Chinese medicines. Beijing, China: The People's Hygiene Press , 1997.
46.
Zhang GJ . The encyclopaedia of Chinese medicines. He'erbin City: Heilongjiang Press , 1995.
